| scholarly article | Q13442814 |
| P2093 | author name string | Sakamoto S | |
| Kanno J | |||
| Ohkusa T | |||
| Okayasu I | |||
| Kajiura K | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Human colon tumors.Enzymic and histological characteristics | Q34158160 | ||
| Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years | Q34392483 | ||
| Risk of malignant change in ulcerative colitis | Q35003049 | ||
| The Correlation of Experimental Carcinogenesis and Cancer in Man | Q39979303 | ||
| Dysplasia and Malignancy in Inflammatory Bowel Disease | Q40177007 | ||
| Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. | Q41418413 | ||
| Colonic cancer induced by 1,2-dimethylhydrazine: promotion by experimental colitis | Q41982593 | ||
| Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium | Q43221786 | ||
| Properties of thymidine kinase partially purified from human fetal and adult tissue. | Q44583380 | ||
| A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice | Q44753508 | ||
| A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues | Q46272421 | ||
| Bacteriological studies of experimental ulcerative colitis | Q46784932 | ||
| Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. | Q50714369 | ||
| Relative activities of thymidylate synthetase and thymidine kinase in 1,2-dimethylhydrazine-induced colon carcinomas in rats. | Q53530520 | ||
| Increased activity of thymidine kinase isozyme in human colon tumor. | Q53554225 | ||
| A study on carcinogenesis induced by degraded carrageenan arising from squamous metaplasia of the rat colorectum | Q53568879 | ||
| Induction by degraded carrageenan of colorectal tumors in rats | Q53586723 | ||
| Investigations into the metabolism and mode of action of the colon carcinogen 1, 2-dimethylhydrazine | Q67365327 | ||
| Degraded carrageenan-induced colitis in CF1 mice. A clinical, histopathological and kinetic analysis | Q70587209 | ||
| Population changes in immunoglobulin-containing mononuclear cells in dextran sulfate sodium-induced coltitis | Q71188969 | ||
| Thymidylate synthetase from amethopterin- resistant Lactobacillus casei | Q71745804 | ||
| Changes in bacterial phagocytosis of macrophages in experimental ulcerative colitis | Q72237740 | ||
| The prognostic significance of direct extension of carcinoma of the colon and rectum | Q73485549 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 87-92 | |
| P577 | publication date | 1996-07-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Promotion of colorectal neoplasia in experimental murine ulcerative colitis | |
| P478 | volume | 39 |
| Q48231667 | A catch-22: Interleukin-22 and cancer |
| Q34275946 | A novel inflammation‐related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate |
| Q54473060 | ATP-binding cassette transporter hallmarks tissue macrophages and modulates cytokine-triggered polarization programs. |
| Q33911395 | Adenoma formation following limited ablation of p120-catenin in the mouse intestine. |
| Q34664017 | An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression |
| Q40637243 | Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis. |
| Q42872084 | Aspirin promotes apoptosis in a murine model of colorectal cancer by mechanisms involving downregulation of IL-6–STAT3 signaling pathway |
| Q36404110 | Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis |
| Q64107236 | CARD9 Signaling in Intestinal Immune Homeostasis and Oncogenesis |
| Q28115443 | CEACAM1 regulates TIM-3-mediated tolerance and exhaustion |
| Q39619078 | CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid |
| Q38011988 | Cancer in inflammatory bowel disease: lessons from animal models |
| Q40183418 | Card9-dependent IL-1β regulates IL-22 production from group 3 innate lymphoid cells and promotes colitis-associated cancer |
| Q36458235 | Celastrol Ameliorates Ulcerative Colitis-Related Colorectal Cancer in Mice via Suppressing Inflammatory Responses and Epithelial-Mesenchymal Transition |
| Q41770220 | Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. |
| Q51043962 | Colitis-accelerated colorectal cancer and metabolic dysregulation in a mouse model. |
| Q26778018 | Colitis-associated colon cancer: Is it in your genes? |
| Q37339787 | Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells |
| Q47400912 | Combination Strategy of Quantitative Proteomics Uncovers the Related Proteins of Colorectal Cancer in the Interstitial Fluid of Colonic Tissue from the AOM-DSS Mouse Model |
| Q24611771 | Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis |
| Q26864198 | Critical role of NF-κB in pancreatic cancer |
| Q53067339 | Crucial involvement of the CCL3-CCR5 axis-mediated fibroblast accumulation in colitis-associated carcinogenesis in mice. |
| Q34525747 | Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice |
| Q88548168 | Cytoglobin affects tumorigenesis and the expression of ulcerative colitis-associated genes under chemically induced colitis in mice |
| Q35596524 | Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium |
| Q38011771 | Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence |
| Q41643735 | Dietary cocoa protects against colitis-associated cancer by activating the Nrf2/Keap1 pathway |
| Q34826294 | Dietary selenium deficiency exacerbates DSS-induced epithelial injury and AOM/DSS-induced tumorigenesis |
| Q36678366 | Down regulation by a low-zinc diet in gene expression of rat prostatic thymidylate synthase and thymidine kinase |
| Q37260742 | Downregulation of hematopoietic MUC1 during experimental colitis increases tumor-promoting myeloid-derived suppressor cells |
| Q44118739 | Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model |
| Q44593818 | Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice |
| Q50152803 | Enhanced cell kinetics, p53 accumulation and high p21WAF1 expression in chronic cholecystitis: comparison with background mucosa of gallbladder carcinomas |
| Q35920677 | Ets2 regulates colonic stem cells and sensitivity to tumorigenesis |
| Q26747341 | Fibroblasts, an inconspicuous but essential player in colon cancer development and progression |
| Q36733448 | Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis. |
| Q27310820 | Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma |
| Q33752847 | Genomic variants in mouse model induced by azoxymethane and dextran sodium sulfate improperly mimic human colorectal cancer. |
| Q37983752 | Heparanase enzyme in chronic inflammatory bowel disease and colon cancer |
| Q34876266 | Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice |
| Q38828488 | High-fat diet induced leptin and Wnt expression: RNA-sequencing and pathway analysis of mouse colonic tissue and tumors |
| Q33550441 | High-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis |
| Q34028645 | Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation |
| Q36302527 | IEX-1 deficiency protects against colonic cancer |
| Q36060253 | IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity. |
| Q35013368 | IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation |
| Q28506198 | IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine |
| Q35151772 | Identification of gene expression changes from colitis to CRC in the mouse CAC model |
| Q27861048 | Immunity, Inflammation, and Cancer |
| Q35099711 | Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice |
| Q41193411 | Increase in dietary protein content exacerbates colonic inflammation and tumorigenesis in azoxymethane-induced mouse colon carcinogenesis |
| Q37292693 | Inducible heat shock protein 70 prevents multifocal flat dysplastic lesions and invasive tumors in an inflammatory model of colon cancer |
| Q36597803 | Inflammation and colorectal cancer: colitis-associated neoplasia |
| Q37733245 | Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer |
| Q37731507 | Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer |
| Q30488671 | Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease |
| Q35147203 | MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma model |
| Q33652022 | Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer |
| Q35190405 | MicroRNA profiling in Muc2 knockout mice of colitis-associated cancer model reveals epigenetic alterations during chronic colitis malignant transformation |
| Q38826706 | Murine Model for Colitis-Associated Cancer of the Colon |
| Q36925725 | NF-kappaB and the intestine: friend or foe? |
| Q37412699 | NF-kappaB as a critical link between inflammation and cancer |
| Q37995696 | NF-κB and the link between inflammation and cancer |
| Q36795773 | NF-κB pathway in colitis-associated cancers |
| Q91676713 | Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis |
| Q29547879 | Nuclear factor-kappaB in cancer development and progression |
| Q99636824 | Organoid Models of Colorectal Pathology: Do They Hold the Key to Personalized Medicine? A Systematic Review |
| Q35742156 | Parthenolide induces apoptosis in colitis-associated colon cancer, inhibiting NF-κB signaling |
| Q49787846 | Phospholipase Cγ1 links inflammation and tumorigenesis in colitis-associated cancer |
| Q53399282 | Protective function of interleukin 27 in colitis-associated cancer via suppression of inflammatory cytokines in intestinal epithelial cells. |
| Q37566592 | RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer |
| Q37600049 | Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation. |
| Q41778061 | Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice |
| Q53296152 | Role of different inflammatory and tumor biomarkers in the development of ulcerative colitis-associated carcinogenesis. |
| Q36040176 | Selenoprotein P influences colitis-induced tumorigenesis by mediating stemness and oxidative damage |
| Q39889562 | Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis |
| Q36101233 | Significance of heparanase in cancer and inflammation |
| Q30446315 | Simultaneous follow-up of mouse colon lesions by colonoscopy and endoluminal ultrasound biomicroscopy |
| Q38017601 | Stromal biomarkers in breast cancer development and progression |
| Q49316629 | Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice |
| Q35823094 | Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis |
| Q93046175 | Synbiotics suppress colitis-induced tumorigenesis in a colon-specific cancer mouse model |
| Q36325314 | Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma |
| Q34772160 | The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies |
| Q41203716 | The Extracts of Morinda officinalis and Its Hairy Roots Attenuate Dextran Sodium Sulfate-Induced Chronic Ulcerative Colitis in Mice by Regulating Inflammation and Lymphocyte Apoptosis |
| Q28270208 | The IkappaB kinase - a bridge between inflammation and cancer |
| Q48419590 | The Synaptojanins in the murine small and large intestine |
| Q35117031 | The gut microbiota in mouse models of inflammatory bowel disease |
| Q33634666 | The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia |
| Q30481023 | Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors |
| Q95721208 | Troglitazone, a ligand for peroxisome proliferator-activated receptor gamma, inhibits chemically-induced aberrant crypt foci in rats |
| Q42109061 | Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer |
| Q34983857 | Unique haploinsufficient role of the microRNA-processing molecule Dicer1 in a murine colitis-associated tumorigenesis model. |
| Q35741699 | Up-regulation of matrix metalloproteinases in a mouse model of chemically induced colitis-associated cancer: the role of microRNAs |
| Q37250270 | Vam3, a Compound Derived from Vitis amurensis Rupr., Attenuated Colitis-Related Tumorigenesis by Inhibiting NF-κB Signaling Pathway |
| Q42075331 | Vitamin A Inhibits Development of Dextran Sulfate Sodium-Induced Colitis and Colon Cancer in a Mouse Model |
| Q36906454 | Vitamin D receptor and retinoid X receptor α status and vitamin D insufficiency in models of murine colitis |
| Q83576324 | Whey protein versus whey protein hydrolyzate for the protection of azoxymethane and dextran sodium sulfate induced colonic tumors in rats |
| Q90668894 | miR-370-3p Alleviates Ulcerative Colitis-Related Colorectal Cancer in Mice Through Inhibiting the Inflammatory Response and Epithelial-Mesenchymal Transition |
Search more.